Outsourcing Facilities Association et al v. United States Food and Drug Administration et al

  1. October 22, 2024

    Drug-Shortage List Under Scrutiny After FDA Reversal

    A federal agency's unusual flip-flop this month on whether to allow copycat versions of a lucrative weight-loss and diabetes drug may cause regulators to move more cautiously as they weigh how to handle future drug shortages.